Results 121 to 130 of about 1,702,455 (203)

When Platelet Stimulation Becomes Marrow Stress: Rethinking Thrombopoietin Receptor Agonist Intensification in Pediatric Immune Thrombocytopenia. [PDF]

Pediatr Rep
Aricò M.
europepmc   +1 more source

Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters. [PDF]

Eur J Clin Pharmacol, 2020
Katsube T, Inoue Y, Fukuhara T, Kano T, Wajima T.   +4 more
europepmc   +1 more source

Avatrombopag in thrombopoietin receptor agonist-naïve patients with immune thrombocytopenia: real-world treatment patterns and clinical outcomes from the REAL-AVA 3.0 study. [PDF]

Res Pract Thromb Haemost
Panch S, Oladapo A, Kolodny S, Vredenburg M, Lucht S, Bland E, Pathak P, Feinberg B, Jiang D.   +8 more
europepmc   +1 more source

Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel.

Acta Haematol, 2021
Cooper N, Hill QA, Grainger J, Westwood JP, Bradbury C, Provan D, Thachil J, Ramscar N, Roy A.   +8 more
europepmc   +1 more source

Repurposing lusutrombopag: unveiling anti-Staphylococcus aureus activity in a novel oral thrombopoietin receptor agonist. [PDF]

BMC Microbiol
Li C, Huang X, Lan Q, Wen Z, Yu Z, Chen Z, Xu Z, Li P.   +7 more
europepmc   +1 more source

Pembrolizumab-Induced Aplastic Anemia Successfully Treated With Thrombopoietin Receptor Agonist in a Patient With Lung Adenocarcinoma: A Case Report and Literature Review. [PDF]

Cureus
Namba K, Isobe K, Nakao S, Hiruta N, Wakabayashi H.   +4 more
europepmc   +1 more source

Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trial. [PDF]

J Hematol Oncol
Wu R, Gao J, Liu Y, Yu J, Hu S, Liang H, Jiang H, Zhai X, Zhou M, Hao W, Mei H, Li F, Chen Y, Liu W, Yan M, Li R, Xiong J, Zhu Z, Cheng X, Wang T.   +19 more
europepmc   +1 more source

Combination Therapy with Romiplostim, Danazol, and a Thrombopoietin Receptor Agonist for Immune Restoration in Chronic Refractory Immune Thrombocytopenia: A Case Series. [PDF]

Immunotargets Ther
Wang SX, Tan GM, Zou ZM, Zou LF, Tu YC, Kong FC, Xie X, Li F.   +7 more
europepmc   +1 more source

The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia. [PDF]

Ann Hematol
Li J, Shi Y, Zhang B, Yang W, Jing L, Zhang L, Han B, Shi J, Yuan W, Li S, Zhang F, Zhao X.   +11 more
europepmc   +1 more source